Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone vs Buprenorphine for Heroin Dependence in Malaysia
NCT00383045Phase 2Completed
- Sponsor
- Yale University
- Start
- Apr 2003
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of naltrexone and buprenorphine in opioid use disorder (OUD) (3 arms), sponsored by Yale University. Primary endpoints: Time to resumption of heroin use, Time to relapse and 2 more. Started Apr 2003; status: completed.
02
Drugs
naltrexonebuprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00383045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383045.